Clinical Trials
3 trialsNCT03374215 2026-06-05
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05804669 2026-06-04
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Crinetics Pharmaceuticals Inc.
Phase 1/2 Recruiting
NCT03604198 2026-04-21
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting